Abstract:
PURPOSE: A biocompatible and temperature-sensitive polyethylene eglycol/polyester block copolymer is provided to form the gel within the human body since the phase transition is enabled by the temperature change and to enable the use as the substrate of different forms for cell and tissue cultivation. CONSTITUTION: A biocompatible and temperature-sensitive polyethylene eglycol/polyester block copolymer comprises a hydrophilic part including polyethylene glycol and a biocompatible polyester-based hydrophobic part including a caprolactone segment and a lactide segment at the same time, wherein the molar ratio of the caprolactone segment and the lactide segment is 94 : 6 ~ 99 : 1. The copolymer is a sol phase at the room temperature and a gel phase at 30~50 °C.
Abstract:
PURPOSE: A biocompatible and temperature-sensitive polyethylene eglycol/polyester block copolymer is provided to form the gel within the human body since the phase transition is enabled by the temperature change and to enable the use as the substrate of different forms for cell and tissue cultivation. CONSTITUTION: A biocompatible and temperature-sensitive polyethylene eglycol/polyester block copolymer comprises a hydrophilic part including polyethylene glycol and a biocompatible polyester-based hydrophobic part including a caprolactone segment and a lactide segment at the same time, wherein the molar ratio of the caprolactone segment and the lactide segment is 94 : 6 ~ 99 : 1. The copolymer is a sol phase at the room temperature and a gel phase at 30~50 °C.
Abstract:
PURPOSE: A drug-containing polymer microsphere and a method for manufacturing the same are provided to enhance molecular motion and to enhance yield of microsphere. CONSTITUTION: A drug-containing polymer microsphere comprises: a hydrophilic part C2-C10 alcohol or polyalkylene glycol; a biodegradable polyester hydrophobic part containing cyclic ester segment and lactide segment; and a drug. A method for manufacturing the microsphere comprises: a step of polymerizing polyalkylene glycol or C2-C10 alcohol with cyclic ester and lactide at 90-150 °C to prepare a polymer having 1,000-100,000 g/mole of molecular weight; a step of adding drug to the polymer; and a step of dispersing drug in an emulsifier to form a microsphere.